An Open-Label, Double Conversion Study to Characterize the Pharmacokinetics of Lamotrigine When Switching Patients With Epilepsy on LAMICTAL Immediate-Release to Extended-Release Formulation and Vice Versa
Phase of Trial: Phase III
Latest Information Update: 25 Sep 2016
At a glance
- Drugs Lamotrigine (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 15 Oct 2008 Actual start date changed from Aug 2005 to Oct 2005 as reported by clinicalTrials.gov.
- 14 Oct 2008 Trial phase changed from II/III to III as reported by ClinicalTrials.gov.
- 15 Sep 2006 New trial record.